Furthermore, weak and partial CD30 positivity can be seen in the neoplastic cells of NLPHL, and such a finding by itself is not sufficient for a diagnosis of CHL without the other typical immunophenotypic features of this neoplasm [9]. This evidence concerns the gene TNFRSF8 and classic Hodgkin lymphoma.